Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 3
1950 1
1951 3
1952 1
1953 1
1954 1
1957 1
1958 1
1959 1
1962 1
1963 1
1964 9
1965 5
1966 3
1967 1
1968 1
1969 1
1971 1
1973 1
1976 2
1978 2
1979 4
1980 2
1981 3
1982 1
1983 1
1984 3
1985 1
1986 2
1988 3
1990 2
1991 3
1992 3
1996 1
1997 1
1998 1
2000 1
2001 2
2002 1
2003 4
2004 7
2005 12
2006 6
2007 5
2008 5
2009 6
2010 9
2011 10
2012 11
2013 8
2014 13
2015 7
2016 9
2017 13
2018 4
2019 16
2020 17
2021 14
2022 21
2023 17
2024 11
2025 14
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nisenbaum e[au] (88 results)?
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.
Nacev BA, Sanchez-Vega F, Smith SA, Antonescu CR, Rosenbaum E, Shi H, Tang C, Socci ND, Rana S, Gularte-Mérida R, Zehir A, Gounder MM, Bowler TG, Luthra A, Jadeja B, Okada A, Strong JA, Stoller J, Chan JE, Chi P, D'Angelo SP, Dickson MA, Kelly CM, Keohan ML, Movva S, Thornton K, Meyers PA, Wexler LH, Slotkin EK, Glade Bender JL, Shukla NN, Hensley ML, Healey JH, La Quaglia MP, Alektiar KM, Crago AM, Yoon SS, Untch BR, Chiang S, Agaram NP, Hameed MR, Berger MF, Solit DB, Schultz N, Ladanyi M, Singer S, Tap WD. Nacev BA, et al. Among authors: rosenbaum e. Nat Commun. 2022 Jun 15;13(1):3405. doi: 10.1038/s41467-022-30453-x. Nat Commun. 2022. PMID: 35705560 Free PMC article.
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Smith M, Parker C, Saad F, Miller K, Tombal B, Ng QS, Boegemann M, Matveev V, Piulats JM, Zucca LE, Karyakin O, Kimura G, Matsubara N, Nahas WC, Nolè F, Rosenbaum E, Heidenreich A, Kakehi Y, Zhang A, Krissel H, Teufel M, Shen J, Wagner V, Higano C. Smith M, et al. Among authors: rosenbaum e. Lancet Oncol. 2019 Mar;20(3):408-419. doi: 10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6. Lancet Oncol. 2019. PMID: 30738780 Clinical Trial.
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Movva S, Seier K, Avutu V, Banks LB, Chan J, Chi P, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Maki R, Rosenbaum E, Salcito T, Rodriguez K, Dempsey R, Meyers PA, Cohen SM, Hensley ML, Konner JA, Schram AM, Lefkowitz RA, Erinjeri JP, Qin LX, Tap WD, D'Angelo SP. Movva S, et al. Among authors: rosenbaum e. Clin Cancer Res. 2024 Dec 16;30(24):5612-5619. doi: 10.1158/1078-0432.CCR-24-2519. Clin Cancer Res. 2024. PMID: 39405335 Free PMC article.
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial.
Antonarakis ES, Park SH, Goh JC, Shin SJ, Lee JL, Mehra N, McDermott R, Sala-Gonzalez N, Fong PC, Greil R, Retz M, Sade JP, Yanez P, Huang YH, Begbie SD, Gafanov RA, De Santis M, Rosenbaum E, Kolinsky MP, Rey F, Chiu KY, Roubaud G, Kramer G, Sumitomo M, Massari F, Suzuki H, Qiu P, Zhang J, Kim J, Poehlein CH, Yu EY. Antonarakis ES, et al. Among authors: rosenbaum e. J Clin Oncol. 2023 Aug 1;41(22):3839-3850. doi: 10.1200/JCO.23.00233. Epub 2023 Jun 8. J Clin Oncol. 2023. PMID: 37290035 Free PMC article. Clinical Trial.
Conjunctival tick bite.
Chu KH, Kwok A, Grigorian AP, Block JB, Rosenbaum E, Elhusseiny AM. Chu KH, et al. Among authors: rosenbaum e. Eye (Lond). 2025 Apr 1. doi: 10.1038/s41433-025-03770-w. Online ahead of print. Eye (Lond). 2025. PMID: 40169884 No abstract available.
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.
Luan D, Ben Valid O, Beyar-Katz O, Tix T, Accav NG, Alhomoud M, Avigdor A, Bücklein VL, Cohen L, Dahi PB, Einarsdottir S, Elimelech J, Escribano-Serrat S, Falchi L, Fei T, Giralt S, Gomez-Llobell M, Goy A, Horesh N, Israeli S, Kruk L, Leslie L, Lue JK, Marcus R, Nagler A, Palomba ML, Park JH, Raj S, Reddy S, Romancik J, Rosenbaum E, Salles G, Scordo M, Shah GL, Shimoni A, von Bergwelt-Baildon M, Perales MA, Subklewe M, Greenbaum U, Ip A, Ram R, Rejeski K, Shouval R. Luan D, et al. Among authors: rosenbaum e. Blood. 2026 Mar 19;147(12):1315-1322. doi: 10.1182/blood.2025031476. Blood. 2026. PMID: 41489404 Free PMC article.
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.
Kelly CM, Qin LX, Whiting KA, Richards AL, Avutu V, Chan JE, Chi P, Dickson MA, Gounder MM, Keohan ML, Movva S, Nacev BA, Rosenbaum E, Adamson T, Singer S, Bartlett EK, Crago AM, Yoon SS, Hwang S, Erinjeri JP, Antonescu CR, Tap WD, D'Angelo SP. Kelly CM, et al. Among authors: rosenbaum e. Clin Cancer Res. 2023 Jun 1;29(11):2043-2051. doi: 10.1158/1078-0432.CCR-22-3911. Clin Cancer Res. 2023. PMID: 36971773 Free PMC article. Clinical Trial.
Implementing Whole Person Primary Care.
Rosenbaum E, Gordon AE, Cresta J, Shaughnessy AF, Jonas WB. Rosenbaum E, et al. Ann Fam Med. 2023 Mar-Apr;21(2):188. doi: 10.1370/afm.2952. Ann Fam Med. 2023. PMID: 36973056 Free PMC article. No abstract available.
The Art of Health Promotion: linking research to practice.
Grossmeier J, Calitz C, Pham K, Lang JE, Mummert A, Roemer EC, Kent KB, Koffman DM, Goetzel RZ, Rosenbaum E, Imboden M, Noeldner S, Martin S, Picarella R, Pitts JS. Grossmeier J, et al. Among authors: rosenbaum e. Am J Health Promot. 2020 Mar;34(3):316-332. doi: 10.1177/0890117119898026. Epub 2020 Jan 30. Am J Health Promot. 2020. PMID: 31997654 No abstract available.
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma.
Movva S, Seier K, Bradic M, Charalambous K, Rosenbaum E, Kelly CM, Cohen SM, Hensley ML, Avutu V, Banks LB, Chan JE, Chi P, D'Angelo S, Dickson MA, Gounder MM, Keohan ML, Maki RG, Green A, Makker V, Rubinstein MM, Saunds S, Cho JM, Lefkowitz RA, Erinjeri J, Qin LX, Shah R, Wong P, Tap W. Movva S, et al. Among authors: rosenbaum e. J Immunother Cancer. 2025 Jun 12;13(6):e012020. doi: 10.1136/jitc-2025-012020. J Immunother Cancer. 2025. PMID: 40514070 Free PMC article. Clinical Trial.
293 results